title: Cardiac biomarkers: new tools for heart failure management.
abstract: The last decade has seen exciting advances in the field of biomarkers used in managing patients with heart failure (HF). Biomarker research has broadened our knowledge base, shedding more light on the underlying pathophysiological mechanisms occurring in patients with both acute and chronic HF. The criterion required by an ideal cardiovascular biomarker has been progressively changing to an era of sensitive assays that can be used to guide treatment. Recent technological advances have made it possible to rapidly measure even minute amounts of these proteins by means of higher sensitivity assays. With a high prevalence of comorbidities associated with HF, an integrated approach utilizing multiple biomarkers have shown promise in predicting mortality, better risk stratification and reducing re-hospitalizations, thus lowering health-care costs. This review provides a brief insight into recent advances in the field of biomarkers currently used in the diagnosis and prognosis of patients with acute and chronic HF.
authors.affiliation: Veterans Affairs San Diego Healthcare System, San Diego, CA, USA;
authors.forename: Navaid
authors.initials: N
authors.lastname: Iqbal
authors.forename: Bailey
authors.initials: B
authors.lastname: Wentworth
authors.forename: Rajiv
authors.initials: R
authors.lastname: Choudhary
authors.forename: Alejandro De La Parra
authors.initials: Ade L
authors.lastname: Landa
authors.forename: Benjamin
authors.initials: B
authors.lastname: Kipper
authors.forename: Arrash
authors.initials: A
authors.lastname: Fard
authors.forename: Alan S
authors.initials: AS
authors.lastname: Maisel
keywords: Decompensated heart failure; cardiac myocyte; glomerular filtration rate; natriuretic peptides